BioSig Allowed First Key US Patent Claims for its PURE EP™ System
23 mai 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, May 23, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version
21 mai 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, May 21, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
SetPoint Medical Reports New Data Demonstrating its Bioelectronic Medicine Effectively Reduces Crohn’s Disease Activity
20 mai 2019 09h00 HE
|
SetPoint Medical
VALENCIA, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced new positive...
Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors
20 mai 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Completes Patient Cases at Indiana University
06 mai 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, May 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig’s Manuscript Accepted to IEEE Engineering in Medicine and Biology Conference 2019
02 mai 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, May 02, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig To Participate at Heart Rhythm Society’s Scientific Sessions 2019
30 avr. 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, April 30, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Frank J. Quintero Joins BioSig Technologies Advisory Board
09 avr. 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, April 09, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
D.A. Wallach Joins BioSig Technologies Advisory Board
26 mars 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, March 26, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Endonovo Therapeutics Files Patent on Bioelectronic Technology, Devices and Therapies
02 sept. 2014 09h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(Marketwired - Sep 2, 2014) - Endonovo Therapeutics, Inc. (OTCQB: ENDV), a developer of novel cell-free therapies, announced today that it has filed a patent on bioelectronic...